Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • Analyst Insights & IR
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Alteogen (196170) Completes 100% Payment of KRW 155B Third-Party Placed Redeemable Convertible Preferred Shares; 1-Year Lock-up Period Applied

Posted on February 19, 2025July 11, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen (196170) Completes 100% Payment of KRW 155B Third-Party Placed Redeemable Convertible Preferred Shares; 1-Year Lock-up Period Applied

Source Fact: Financial Supervisory Service Electronic Disclosure System (DART) / 2025-02-19

Disclosure Type: Result of Securities Issuance (Voluntary Disclosure)

💡 3-Second Summary

Alteogen has successfully secured approximately KRW 155 billion in cash as the full payment for its third-party allocated Redeemable Convertible Preferred Shares (RCPS) has been completed.

📊 1. [Key Disclosure Content & Major Figures Summary]

  • Type of Securities: Registered Redeemable Convertible Preferred Shares (RCPS)
  • Issuance Method: Third-party allocation paid-in capital increase
  • Issuance & Actual Payment Figures:
    • Number of Shares Issued: 434,848 shares (100% fully paid as scheduled)
    • Actual Amount Raised: KRW 154,994,177,184 (Approx. KRW 155B)
  • Key Timeline:
    • Payment Date: February 19, 2025
    • Expected Date of New Share Delivery: March 5, 2025 (Subject to change based on consultations with relevant authorities)
  • Lock-up Condition: The newly issued RCPS will be subject to a mandatory 1-year lock-up period at the Korea Securities Depository (KSD) from the delivery date.
  • Scheduled Listing Status: No (Unlisted)

📈 2. [Expert View: What This Disclosure Means for Investors]

  • Securing Financial Liquidity & Eliminating Funding Uncertainty: The massive funding of KRW 155 billion was 100% completed without any payment defaults just two weeks after the initial board resolution (February 4, 2025). As the cash has actually cleared, this injection may significantly strengthen the company’s financial stability for pipeline development and clinical trials.
  • Prevention of Short-Term Overhang Risk: All newly issued shares are bound by a mandatory 1-year lock-up period at the Korea Securities Depository. This effectively mitigates the immediate risk of a massive stock supply flooding the market and applying downward pressure on the stock price.
  • Investor Caution: Although these shares are issued as unlisted RCPS, investors should monitor the potential long-term dilution rate and future financial redemption burdens, as these shares can later be converted into common stock or requested for redemption depending on investor demands.

📝 Editor’s Comment (by K-STOCK Editor)

This is not one of those stressful capital raises where promises are made but the money never arrives. Alteogen has cleanly landed a whopping KRW 155 billion into its bank account in just two weeks, scoring a 100% success rate on its fundraising mission. The most comforting news for the market is that this massive block of shares will be under lock and key for a full year. With the war chest stacked and immediate overhang fears completely put to rest, the market’s focus is highly likely to shift toward how this capital will fuel the next pipeline engine.

📢 Disclaimer & Source Information

Source: This content was structured and newly written based on the official submitted data from the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Samsung Electronics (005930) Formally Approves KRW 3.05T Share Retirement… 57 Million Common and Preferred Shares Permanently Extinguished
Next Post: [Disclosure] HANMI Semiconductor (042700) to Convene Annual Meeting: Tabling 720 KRW Cash Dividend & Re-appointment of CEO Dong-Shin Kwak

Related Posts

[Disclosure] Alteogen (196170) Designated as Investment Warning Stock Due to Share Price Surge; Trading May Be Suspended Upon Further Gains Disclosures
[Disclosure] Alteogen (196170) Hits Jackpot: Signs KRW 867.5B Exclusive License Deal with Global Big Pharma Biogen for ALT-B4 Bio & Healthcare
[Disclosure] Alteogen(196170) to List 170,300 Additional Common Shares Following Exercise of Stock Options Disclosures
[Disclosure] Alteogen (196170) Escapes Unfaithful Disclosure Penalty; Korea Exchange Decides ‘Non-designation’ Over Two Cases of Altered Disclosures Disclosures
[Disclosure] Alteogen(196170) Announces Yearend Cash Dividend of KRW 20.0B, Paying KRW 371 Per Share Disclosures
[Disclosure] Alteogen(196170) to Acquire 859,018 New Shares of Altos Biologics via Subsidiary Merger (No Additional Capital Outflow) Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hana Micron (067310) Lifted from Investment Warning Stock Status; Reclassified to Investment Caution on June 9 with Re-designation WarningJuly 8, 2026
  • [Discount Reversal via ADR Listing and Entry into an HBM-Led Super Cycle: SK hynix 000660]July 7, 2026
  • [Discount Narrowing via ADR Listing Momentum and Capital Allocation Diversification: SK Square 402340]July 7, 2026
  • Gaon Cable (000500): Structural Re-rating Driven by North American Infrastructure Expansion and AI Data Center Demand ShocksJuly 7, 2026
  • Hugel (145020): Passing the Trough with Q2 Earnings Surprise and Accelerated U.S. Direct Sales DeploymentJuly 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme